Insilico and ASKA partner to advance AI-driven gynecological drug discovery
Mar 24 2026
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. ("ASKA"), a specialized pharmaceutical company...
Modified Lipid Nanoparticles Boost mRNA Vaccine Delivery to Lymph Nodes
Lipid nanoparticles have become the workhorse of mRNA vaccines, ferrying genetic cargo into cells so the immune system can learn to recognize a threat. But most LNPs don’t travel where vaccine developers would ideally...
Lab-grown food pipe offers hope for children with esophageal conditions
Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown esophagus - the food pipe - shown to safely replace a full section of the organ and...
Study identifies protein that slows cartilage breakdown in joints
Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders worldwide, particularly among aging populations. The disease is characterized...
Scientists identify new target to slow Huntington’s disease progression
Huntington's disease is a devastating brain disorder that slowly robs people of movement, memory and personality. It is caused by a toxic protein that builds in brain cells and ultimately kills them. For years,...
Computational Model Predicts Telomere Length from Images of Routine Histopathology Slides
Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a new computational tool, TLPath, that can infer changes occurring at the ends of chromosomes—the telomeres—by detecting structural alterations in cells and tissues captured...
Commercializing Autologous Cell Therapy: Bridging Clinical and Large-Scale Manufacturing
Register Now Panelists:
Pascal Touchon Board Member – RoslinCT Global Strategy AdvisorRoslinCT View Bio
Panelist ...
Baylor College of Medicine Taps Nautilus’ Voyager for Cancer Proteomics
Nautilus Biotechnology has announced Baylor College of Medicine as the first customer of the early access program for its proteomics technology. As part of the program, Baylor will use Nautilus’ single-molecule proteomics method to...
Dual-Vector System Generates CAR T Cells In Vivo
Manufacturing CAR T cell therapy—one of the most powerful weapons against certain blood cancers—has to date involved an elaborate process, through which doctors first extract a patient’s immune cells and ship them to a...
New approach tracks metabolic fingerprints of tuberculosis-infected human cells
Researchers from King's College London and the University of Surrey have developed a new technique to measure the content of individual human cells infected with bacteria that model tuberculosis – and it is already...
